Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in DYAI — Dyadic International Inc

CIK 1595888 NEW YORK, NY
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,094
+$14,381 QoQ
Shares Held
41,217
+114.1% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 39 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Derivatives in DYAI

reported options exposure · as of Sep 30, 2021
CallValue
$73,392
CallShares
13,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. DYAI ranks #257 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in DYAI

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,094 41,217
2025-09-30 $22,713 19,249
2024-12-31 $44,994 25,711
2021-09-30 $141,517 25,453
2021-09-30 $73,392 13,200
2021-06-30 $57,694 16,071
2020-06-30 $244,098 28,187
2020-03-31 $115,044 22,124